Form 4 for LH Labcorp
Accepted 2025-02-10 00:00:00 ET · period of report 2025-02-06 · accession 0001127602-25-003720 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-10 | 2025-02-06+ | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | M - OptEx | — | +1,299 | 28.8K | +5% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | F - Tax | $247.06 | -394 | 29.0K | -1% | -$97.3K |
| DM | 2025-02-10 | 2025-02-06+ | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | M - OptEx | $0.00 | -1,299 | 2,441 | -35% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-07 | M | A | 112 | — | 29,031.66 | D | — | — | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. |
| 2 | Common | Common Stock | 2025-02-07 | F | D | 149 | $246.27 | 28,919.66 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-07 | M | A | 517 | — | 29,068.66 | D | — | — | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. |
| 4 | Common | Common Stock | 2025-02-06 | F | D | 212 | $247.74 | 28,551.66 | D | — | — | |
| 5 | Common | Common Stock | 2025-02-06 | M | A | 670 | — | 28,763.66 | D | — | — | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. (F2) Amount includes 93.8655 shares acquired on June 30, 2024 and 16.6340 shares acquired on December 31, 2024 under the Labcorp Holdings Inc. Amended and Restated 2016 Employee Stock Purchase Plan. |
| 6 | Common | Common Stock | 2025-02-07 | F | D | 33 | $246.27 | 28,998.66 | D | — | — | |
| 7 | Derivative | Restricted Stock Unit | 2025-02-06 | M | D | 670 | $0.00 | 3,070 | D | — · — to — | 670 Common Stock | (F5) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. (F4) The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025. |
| 8 | Derivative | Restricted Stock Unit | 2025-02-07 | M | D | 517 | $0.00 | 2,553 | D | — · — to — | 517 Common Stock | (F5) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. (F6) The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. |
| 9 | Derivative | Restricted Stock Unit | 2025-02-07 | M | D | 112 | $0.00 | 2,441 | D | — · — to — | 112 Common Stock | (F5) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. (F6) The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. |